Elias Theodorou is the first professional athlete to compete in the U.S. with medical cannabis exemption


Elias Theodorou, an MMA fighter and advocate of medical cannabis, will compete with an exemption for the use of medical cannabis.

Image provided by Jess Moran.

This will be the first U.S. fight with a Therapeutic Use Exemption (TUE) in competition for medical cannabis.

Many athletes have been penalized for the use of medicinal cannabis.

Earlier this year, American sprinter Sha’Carri Richardson was suspended for one month after testing positive for THC.

Elias Theodorou, MMA fighter and advocate of medical cannabis. Image provided by Jess Moran.

Had he been allowed to compete in an AUT, he could have competed in his flagship event at the Tokyo Olympics.

Theodorou’s struggle it is a historic moment for American athletes.

It sets an important precedent for athletes who use medical cannabis.

The event takes place on December 18, 2021 in Greeley, Colorado.

The competition will also be broadcast as a pay-per-view for over 21s.

“Validating my U.S. AUT for cannabis with a fight and an end will officially mark my place in the history of American sport as the first sanctioned cannabis athlete,” says Elias Theodorou.

“This is a precedent not only for me, but for other athletes in Colorado and other states, who in turn can create a wave of opportunities for other athletes to claim the same right to be cannabis medicated in the United States. competition “.

The match will be immortalized by an exclusive NFT for sale on the New World platform.

“I will commemorate my next fight with an NFT that represents the ‘blow’ to the ban on athletics, validating my means of exemption from therapeutic use,” Theodorou said.

The leader of the fight is the middleweight fight between Theodorou and Bellator.

The ticket also includes a fight for the professional welterweight title between Petrosyan and Dunkle, a Super Full Rules Muay Thai super-fight between Martinex and Lacroix and a fight for the bantamweight title between Valadez and Haas.

Source link